Vimarsana
Biggest News Aggregation in the World

Digital Pathology System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Digital Pathology System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Digital Pathology System Today - Breaking & Trending Today

Outlook on the Digital Pathology Global Market to 2027: Featuring 3Dhistech, Apollo Enterprise Imaging, Clinisys and Corista Among Others - Vimarsana News

Outlook on the Digital Pathology Global Market to 2027: Featuring 3Dhistech, Apollo Enterprise Imaging, Clinisys and Corista Among Others

/PRNewswire/ -- The "Digital Pathology: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report includes...

Inspirata, Inc.: Inspirata Announces Issuance of New U.S. Patent for its Digital Pathology System - Vimarsana News

Inspirata, Inc.: Inspirata Announces Issuance of New U.S. Patent for its Digital Pathology System

Inspirata, Inc.: Inspirata Announces Issuance of New U.S. Patent for its Digital Pathology System Tampa, Florida, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,878,025 for its Digital Pathology System. This patent joins Inspirata's portfolio of nine awarded patents and one patent pending. Inspirata has been a thought leader in digital pathology for more than a decade, and the Digital Pathology System patent issuance is strong evidence of In...

Investegate |Inspirata, Inc. Announcements | Inspirata, Inc.: Inspirata Announces Issuance of New U.S. Patent for its Digital Pathology System - Vimarsana News

Investegate |Inspirata, Inc. Announcements | Inspirata, Inc.: Inspirata Announces Issuance of New U.S. Patent for its Digital Pathology System

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...